METHOD OF TREATING CHRONIC TONSILLITIS IN CHILDREN Russian patent published in 2014 - IPC A61K31/00 A61N5/06 A61P11/04 

FIELD: medicine.

SUBSTANCE: method involves drug and irrigation therapy, laser therapy covering a sub-mandibular region; the novel is that drug therapy represents administering the hydrogel sterile material 'Coletex-gel-DNK-L' or 'Coletex-gel-ADL' 1-3 ml into each tonsil lacunas. Laser therapy additionally covers a projection of the common carotid artery, the carotid sinus, internal and external jugulars, the vagus nerve and the upper cervical sympathetic ganglion; these regions and the sub-mandibular region are pre-coated with the sterile textile tissue 'Coletex-AND' or 'Coletex ADL'. The exposure is performed in the infrared band series from both sides at a frequency of 1000 to 1500 Hz, output power 10 to 20 mW, length of exposure 2 to 8 min; after the procedure, the used tissue is left for 6-8 hours; the course consists of 3-10 daily procedures.

EFFECT: sequence of therapeutic procedures enables regaining a structural balance of the immune regulation that provides the central determination of eliminating the immunological reactivity disorders specific for children suffering chronic tonsillitis, eliminating manifested autonomic nervous system imbalance, providing the higher clinical effectiveness.